The General Director of the National Cannabis Control Agency, Mrs. Linda Pustina, the General Director of the National Cannabis Control Agency, held a bilateral meeting on December 2, 2024, with the Senior Advisor of the U.S. Food and Drug Administration (FDA), Mr. Norman Birenbaum. Takimi u fokusua në çështje të rëndësishme që lidhen me zbatimin e kritereve të licencimit, në përputhje me Ligjin nr. 61/2023, “Për kontrollin e kultivimit dhe përpunimit të bimës së cannabis-it dhe prodhimin e nënprodukteve të saj për qëllime mjekësore dhe industriale në Shqipëri” dhe implementimin e GMP-ve.
The discussions focused on fulfilling the detailed and rigorous requirements that entities applying for a license must meet, with the aim of ensuring compliance with the highest standards and specific conditions outlined in the law, as well as the application of federal standards and best manufacturing practices.
Mr. Birenbaum expressed his willingness to support NACC in addressing challenges, helping ensure compliance with international standards and accelerating the development of a safe, sustainable, and competitive industry in Albania.
NACC remains committed to following and implementing the best international practices, ensuring safety and high standards in the production of medical and industrial cannabis in Albania.